<DOC>
	<DOC>NCT00197808</DOC>
	<brief_summary>The purpose of the study is to evaluate the immune responses of UK infants after one or two doses of pneumococcal conjugate vaccine or one or two doses of three different types of meningococcal conjugate vaccine given at either two and three or two and four months of age.</brief_summary>
	<brief_title>Response of United Kingdom (UK) Infants to a Reduced Primary Schedule With Meningococcal C and Pneumococcal Conjugate Vaccines</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Pneumococcal Infections</mesh_term>
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Written informed consent obtained from parent or legal guardian of infant Age 711 weeks at first dose Any contraindications to vaccination as specified in the UK Handbook "Immunisation Against Infectious Disease" (Ed 1996) &lt; 7 weeks or &gt; 11 weeks at first dose</criteria>
	<gender>All</gender>
	<minimum_age>7 Weeks</minimum_age>
	<maximum_age>11 Weeks</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Streptococcus pneumoniae</keyword>
	<keyword>Neisseria meningitidis</keyword>
</DOC>